Binge Eating Disorder—The Point Prevalence among Polish Women with Polycystic Ovary Syndrome and Validity of Screening Tool for This Population

Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders which is associated with an increased risk of metabolic dysregulation. The elevated prevalence of obesity has been observed in women with PCOS. Since obesity is commonly associated with eating disturbances, including the binge eating disorder (BED), and since the hormonal changes in PCOS patients could influence the food intake model, we decided to estimate the prevalence of BED in PCOS patients and to assess the sensitivity and specificity of the Questionnaire for Binge Eating Screening (QBES) in PCOS patients. Methods: A total of 122 hospitalized women with PCOS aged 16–45 (M = 26; SD = 5.22) took part in the study. Binge eating disorder (BED) was diagnosed according to the DSM-5 diagnostic criteria. QBES was used as a screening tool for BED. Results: The point prevalence of BED in PCOS women according to DMS-5 criteria was 51 (42%). At least two positive answers to four QBES items had 100% sensitivity and 91% specificity. Positive answers to even only the first two questions from QBES had 98% sensitivity and 85% specificity. Conclusions: Women with polycystic ovary syndrome are at a very high risk of binge eating behaviors. Screening for eating disorders should be a routine procedure in women with PCOS. The first two questions from QBES are a brief and relatively reliable screening tool that may be used in everyday practice with POSC patients.

Prevalence and Etiology of Eating Disorders in Polycystic Ovary Syndrome: A Scoping Review

“…Study and participant characteristics are summarized in Table 5 . Six of the included studies were conducted in the United States [ 22 , 70 , 81 , 83 , 93 , 95 ], 6 in the United Kingdom [ 64 , 73 , 78 , 87 , 89 , 94 ], 5 in Turkey [ 66 , 68 , 69 , 74 , 84 ], 4 in Australia [ 28 , 71 , 79 , 92 ], 3 in Sweden [ 65 , 75 , 77 ], 2 in the Netherlands [ 82 , 96 ], and 2 in Poland [ 88 , 91 ]. One each of the remaining studies was conducted in Saudi Arabia [ 85 ], France [ 67 ], Iran [ 72 ], Slovenia [ 97 ], Latvia [ 76 ], Greece [ 86 ], Brazil [ 90 ], and Italy [ 80 ].…”

“…Different criteria were used to diagnose PCOS in studies. A PCOS diagnosis is defined in the international evidence-based guideline for the assessment and management of PCOS ( Supplemental Table 1 ) and the Rotterdam criteria was the most commonly used criteria in 17 studies [ 22 , 29 , 62 , 69 , 70 , [74] , [75] , [76] , [77] , 82 , [84] , [85] , [86] , 88 , 91 , 93 , [95] , [96] , [97] ]. Eight studies relied upon a self-reported diagnosis or diagnosis found in the participant’s medical chart [ 28 , 64 , 66 , 68 , 73 , 79 , 81 , 92 ].…”

“…The age of all included participants ranged from 13 y [ 66 , 76 ] to 35.5 ± 5 y [ 80 ], whereas BMI ranged from 21.2 ± 0.3 kg/m2 [ 67 ] to 36.89 ± 7.24 kg/m2 [ 83 ]. However, 10 studies did not report BMI data for ≥1 study subgroup [ 29 , 62 , 65 , 66 , 72 , 80 , [88] , [89] , [90] , [91] ] and 4 studies did not report age data for ≥1 study subgroup [ 29 , 62 , 65 , 77 ].…”

“…To determine the prevalence of individuals with EDs, 12 studies used structured interviews with participants. These included the Structured Clinical Interview 4 [ 80 , 84 , 89 ], the Schedule for Affective Disorders and Schizophrenia in School Age Children interviews [ 66 ], the semistructured Eating Disorder Examination (EDE) [ 87 , 89 ], the Mini-International Neuropsychiatric Interview [ 77 , 90 ], and other psychiatric interviews [ 67 , 75 , 86 , 91 ]. Of these, all used the DSM-IV diagnostic criteria for diagnosing an ED, whereas 1 study [ 91 ] used the most current DSM-5 criteria, and another [ 86 ] did not specify the edition used.…”

“…This left 38 papers that met the eligibility criteria. Of the 38 included studies, 22 are case–control [ 1 , 28 , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] , [83] ], 9 are cross-sectional [ [84] , [85] , [86] , [87] , [88] , [89] , [90] , [91] , [92] ], 3 are cohort [ [93] , [94] , [95] ], 2 are trials [ 96 , 97 ], and 2 are meta-analyses [ 29 , 62 ].

FIGURE 1 Study eligibility, selection, and data extraction.

…”